| 2025-11-24 |
详情>>
内部人交易：
Olive Christopher D.股份减少209.00股
|
| 2025-11-07 |
详情>>
股本变动：
变动后总股本2018.73万股
变动原因 ▼▲
- 原因：
- From June 30,2025 to September 30,2025
Release of restricted stock
Sales of common stock,net of issuance costs
|
| 2025-11-07 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.46美元,归母净利润-927.6万美元,同比去年增长-20.73%
|
| 2025-10-31 |
股东大会：
将于2025-12-17召开股东大会
会议内容 ▼▲
- 1.To elect two directors to the Company's Board of Directors (the "Board"), to serve as Class I directors for a term of three years expiring at the annual meeting of stockholders to be held in 2028 and until each of their successors have been duly elected and qualified.
2.To ratify the selection by the Audit Committee of the Board of CBIZ CPAs P.C. (“CBIZ CPAs”) as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.
3.To consider a non-binding advisory vote to approve the compensation of the Company’s named executive officers.
4.To consider the frequency for stockholders’ non-binding advisory vote on compensation of the Company’s named executive officers.
5.To conduct any other business properly brought before the meeting or any adjournment or postponement thereof.
|
| 2025-08-08 |
详情>>
业绩披露：
2025年中报每股收益-0.34美元,归母净利润-686.7万美元,同比去年增长-39.49%
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-0.18美元,归母净利润-372.3万美元,同比去年增长-62.43%
|
| 2025-03-31 |
详情>>
业绩披露：
2024年年报每股收益-0.94美元,归母净利润-1031.6万美元,同比去年增长80.46%
|
| 2025-03-21 |
股东大会：
将于2025-05-06召开股东大会
会议内容 ▼▲
- 1.To elect one director to the Company's Board of Directors (the "Board"), to serve as a Class III director for a term of three years expiring at the annual meeting of stockholders to be held in 2027 and until their successor has been duly elected and qualified.
2.To ratify the selection by the Audit Committee of the Board of Marcum LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.
3.To conduct any other business properly brought before the meeting or any adjournment or postponement thereof.
|
| 2024-11-08 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.88美元,归母净利润-768.3万美元,同比去年增长74.19%
|
| 2024-11-07 |
财报披露：
美东时间 2024-11-07 盘后发布财报
|
| 2024-10-15 |
复牌提示：
2024-10-15 10:54:48 停牌，复牌日期 2024-10-15 10:59:48
|
| 2024-08-09 |
详情>>
业绩披露：
2024年中报每股收益-0.65美元,归母净利润-492.3万美元,同比去年增长54.39%
|
| 2024-05-13 |
详情>>
业绩披露：
2024年一季报每股收益-0.33美元,归母净利润-229.2万美元,同比去年增长46.31%
|
| 2024-03-15 |
详情>>
业绩披露：
2023年年报每股收益-22.18美元,归母净利润-5278.5万美元,同比去年增长-3.72%
|
| 2024-02-27 |
详情>>
拆分方案：
每50.0000合并分成1.0000股
|
| 2023-11-13 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.27美元,归母净利润-2977.2万美元,同比去年增长25.58%
|
| 2023-11-07 |
股东大会：
将于2023-12-20召开股东大会
会议内容 ▼▲
- 1.To elect one director to the Company's Board of Directors (the "Board"), to serve as a Class II director for a term of three years expiring at the annual meeting of stockholders to be held in 2026 and until their successor has been duly elected and qualified.
2.To ratify the selection by the Audit Committee of the Board of Marcum LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2023.
3.To approve and adopt a proposed amendment to the Company's Certificate of Incorporation (the "Reverse Stock Split Amendment") to effect a reverse stock split of the Company's common stock at a ratio ranging from 1-for-10 shares up to a ratio of 1-for-50 shares, which ratio will be selected by our Board and set forth in a public announcement (the "Reverse Stock Split").
4.To approve, for the purposes of Nasdaq Listing Rule 5635, the issuance of shares of the Company's common stock to Streeterville Capital, LLC ("Streeterville") upon the conversion of an amended promissory note.
5.To approve, for the purposes of Nasdaq Listing Rule 5635, the issuance of shares of the Company's common stock to Lincoln Park Capital, LLC ("Lincoln Park") pursuant to a stock purchase agreement between the Company and Lincoln Park.
6.To conduct any other business properly brought before the meeting or any adjournment or postponement thereof.
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益-0.1美元,归母净利润-1079.3万美元,同比去年增长66.26%
|
| 2022-08-31 |
股东大会：
将于2022-10-14召开股东大会
会议内容 ▼▲
- 1.To elect three directors to the Company's Board of Directors (the "Board"), each to serve as a Class I director for a term of three years expiring at the annual meeting of stockholders to be held in 2025 and until their successors have been duly elected and qualified.
2.To ratify the selection by the Audit Committee of the Board of Marcum LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022.
3.To approve an amendment and restatement of the Company's 2018 Equity Incentive Plan (the "2018 Plan") to (i) increase the maximum number of shares authorized for issuance thereunder by 2,108,164 and (ii) amend certain language relating to the automatic increase ("evergreen") clause within the 2018 Plan to remove the provision that the automatic increase may be calculated based upon 10% of the "post-Closing" outstanding shares.
4.To consider a non-binding advisory vote to approve the compensation of the Company's named executive officers.
5.To consider the frequency for stockholders' non-binding advisory vote on compensation of the Company's named executive officers.
6.To conduct any other business properly brought before the meeting or any adjournment or postponement thereof.
|
| 2021-10-15 |
股东大会：
将于2021-12-02召开股东大会
会议内容 ▼▲
- 1.To elect two directors to the Company's Board of Directors (the "Board"), each to serve as a Class III director for a term of three years expiring at the annual meeting of stockholders to be held in 2024 and until their successors have been duly elected and qualified.
2.To ratify the selection by the Audit Committee of the Board of Marcum LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2021.
3.To conduct any other business properly brought before the meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-10-16 |
股东大会：
将于2020-12-04召开股东大会
会议内容 ▼▲
- 1.To elect two directors to the Company's Board of Directors (the "Board"), each to serve as a Class II director for a term of three years expiring at the annual meeting of stockholders to be held in 2023 and until their successors have been duly elected and qualified.
2.To ratify the selection by the Audit Committee of the Board of Marcum LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2020.
3.To approve, for the purposes of Listing Rule 5635 of the Nasdaq Stock Market, the issuance of shares of the Company's common stock to Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B upon the conversion of certain convertible notes and the exercise of a warrant issued by the Company on July 15, 2020.
4.To approve an amendment and restatement of the Company's 2018 Equity Incentive Plan to increase the maximum number of shares authorized for issuance thereunder by 2,500,000 shares, from 5,227,895 shares to 7,727,895 shares.
5.To approve an amendment to the Company's Certificate of Incorporation to reduce the number of authorized shares of the Company's common stock from 1,000,000,000 to 250,000,000 and preferred stock from 100,000,000 to 25,000,000.
6.To conduct any other business properly brought before the meeting or any adjournment or postponement thereof.
|
| 2019-10-18 |
股东大会：
将于2019-12-05召开股东大会
会议内容 ▼▲
- 1.To elect the Company's Board of Directors (the "Board") nominees, Keith Cowan and Eric Manlunas, to the Board, to hold office until the 2022 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal.
2.To ratify the selection by the Audit Committee of the Board of Marcum LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2019.
3.To conduct any other business properly brought before the meeting.
|
| 2018-08-06 |
股东大会：
将于2018-08-22召开股东大会
会议内容 ▼▲
- 1.A proposal to further amend the Company’s second amended and restated articles of incorporation, which we refer to as the “charter”, in the form set forth in Annex A to the accompanying Proxy Statement, which we refer to as the “Extension Amendment” and such proposal the “Extension Amendment Proposal”, to extend the date by which the Company must (i) consummate a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, recapitalization, exchangeable share transaction or other business combination involving the Company and one or more businesses, which we refer to as a “business combination”, (ii) cease its operations if it fails to complete such business combination, and (iii) redeem or repurchase 100% of the Company’s common stock included as part of the units sold in the Company’s initial public offering that was consummated on August 24, 2016, which we refer to as the “IPO”, from August 24, 2018 to December 26, 2018 or such earlier date as may be determined by the Board, which we refer to as the “Extension”, and such later date, the “Extended Date”;
2.A proposal to amend the Amended and Restated Investment Management Trust Agreement, which we refer to as the “Trust Agreement”, dated May 23, 2018, by and between the Company and Continental Stock Transfer & Trust Company, which we refer to as “Continental”, in the form set forth in Annex B to the accompanying Proxy Statement, to extend the date on which Continental must liquidate the trust account, which we refer to as the “Trust Account”, established in connection with our IPO if the Company has not completed an initial business combination, from August 24, 2018 to December 26, 2018, and to permit the withdrawal of funds from the Trust Account to pay shareholders who properly exercise their redemption rights in connection with the Extension Amendment, which we refer to as the “Trust Amendment” and such proposal the “Trust Amendment Proposal”;
3.A proposal to approve the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Extension Amendment Proposal or the Trust Amendment Proposal, which we refer to as the “Adjournment Proposal”. The Adjournment Proposal will only be presented at the Special Meeting if there are not sufficient votes to approve the Extension Amendment Proposal or the Trust Amendment Proposal.
|
| 2018-05-03 |
股东大会：
将于2018-05-22召开股东大会
会议内容 ▼▲
- 1.a proposal to amend our charter to extend the date by which we have to consummate a business combination from May 24, 2018 to November 26, 2018 or such earlier date as determined by the Board;
2.a proposal to amend our Trust Agreement to extend the date on which Continental must liquidate the Trust Account if we have not completed a business combination, from May 24, 2018 to November 26, 2018, and to permit the withdrawal of funds from the Trust Account to pay shareholders who properly exercise their redemption rights in connection with the Extension Amendment Proposal;
3.a proposal to approve the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Extension Amendment Proposal or the Trust Amendment Proposal.
|
| 2017-11-03 |
股东大会：
将于2017-11-28召开股东大会
会议内容 ▼▲
- 1. To elect three directors to serve as Class I directors on the Company’s Board of Directors (the “Board”) until the 2019 annual meeting of shareholders or until their successors are elected and qualified;
2. To ratify the selection by our Audit Committee of Withum Smith+Brown, PC to serve as our independent registered public accounting firm for the year ending November 30, 2017;
3. Such other matters as may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|